Marinus Pharmaceuticals Stock Price

1.01 (8.69%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Marinus Pharmaceuticals Inc MRNS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.01 8.69% 12.63 15:34:05
Close Price Low Price High Price Open Price Previous Close
11.94 13.00 12.25 11.62
Bid Price Ask Price Spread News
12.60 12.66 0.06 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,191 813,741 $ 12.47 $ 10,146,482 2,257,657 1.00 - 13.08
Last Trade Time Type Quantity Stock Price Currency
15:34:05 750 $ 12.63 USD

Marinus Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 386.22M 30.58M 30.51M $ - $ - -3.96 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Marinus Pharmaceuticals News

Date Time Source News Article
9/29/202016:50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
9/24/202016:01Business WireMarinus Provides Corporate Update on Phase 3 RAISE Trial in..
9/22/202009:24Edgar (US Regulatory)Current Report Filing (8-k)
9/22/202009:14Business WireMarinus Announces One-for-Four Reverse Stock Split
9/14/202017:19Edgar (US Regulatory)Current Report Filing (8-k)
9/14/202016:01Business WireGanaxolone Achieves Primary Endpoint in Phase 3 Trial for..
9/14/202008:05Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRNS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week12.1013.0810.6111.281,331,2610.534.38%
1 Month1.9213.081.733.2919,211,29810.71557.81%
3 Months2.4513.081.513.067,586,16310.18415.51%
6 Months1.8213.081.482.974,108,70410.81593.96%
1 Year1.5313.081.002.722,718,03511.10725.49%
3 Years6.0113.080.773.651,636,5386.62110.15%
5 Years8.2813.080.773.371,261,6824.3552.54%

Marinus Pharmaceuticals Description

Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy.
Your Recent History
Marinus Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200930 19:49:12